xylazine has been researched along with Thyroid Neoplasms in 2 studies
Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.
Thyroid Neoplasms: Tumors or cancer of the THYROID GLAND.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okamura, M | 1 |
| Yasuhara, K | 2 |
| Koujitani, T | 2 |
| Nasu, M | 2 |
| Hirose, M | 2 |
| Mitsumori, K | 2 |
| Takegawa, K | 1 |
| Onodera, H | 1 |
| Takagi, H | 1 |
2 other studies available for xylazine and Thyroid Neoplasms
| Article | Year |
|---|---|
Dose-threshold for thyroid tumor-promoting effects of xylazine in rats.
Topics: Adrenergic alpha-Agonists; Animals; Body Weight; Carcinogenicity Tests; Carcinogens; Dose-Response R | 2003 |
Promoting effects of xylazine on development of thyroid tumors in rats initiated with N-bis(2-hydroxypropyl)nitrosamine and the mechanism of action.
Topics: Adenoma; Animals; Body Weight; Carcinogens; Carcinoma; Dose-Response Relationship, Drug; Female; Hyp | 2001 |